Export 8 results:
Author Title [ Type(Asc)] Year
Filters: Author is Wierzbicki, Michael R  [Clear All Filters]
Journal Article
S. N. Taylor, Marrazzo, J., Batteiger, B. E., Hook, E. W., Seña, A. C., Long, J., Wierzbicki, M. R., Kwak, H., Johnson, S. M., Lawrence, K., and Mueller, J., Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea., N Engl J Med, vol. 379, no. 19, pp. 1835-1845, 2018.
J. M. Marrazzo, Dombrowski, J. C., Wierzbicki, M. R., Perlowski, C., Pontius, A., Dithmer, D., and Schwebke, J., Safety and Efficacy of a Novel Vaginal Anti-infective, TOL-463, in the Treatment of Bacterial Vaginosis and Vulvovaginal Candidiasis: A Randomized, Single-blind, Phase 2, Controlled Trial., Clin Infect Dis, vol. 68, no. 5, pp. 803-809, 2019.
J. D. Klausner, Bristow, C. C., Soge, O. O., Shahkolahi, A., Waymer, T., Bolan, R. K., Philip, S. S., Asbel, L. E., Taylor, S. N., Mena, L. A., Goldstein, D. A., Powell, J. A., Wierzbicki, M. R., and Morris, S. R., Resistance-Guided Treatment of Gonorrhea: A Prospective Clinical Study., Clin Infect Dis, 2020.
C. R. Cohen, Wierzbicki, M. R., French, A. L., Morris, S., Newmann, S., Reno, H., Green, L., Miller, S., Powell, J., Parks, T., and Hemmerling, A., Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis., N Engl J Med, vol. 382, no. 20, pp. 1906-1915, 2020.
K. Page, Melia, M. T., Veenhuis, R. T., Winter, M., Rousseau, K. E., Massaccesi, G., Osburn, W. O., Forman, M., Thomas, E., Thornton, K., Wagner, K., Vassilev, V., Lin, L., Lum, P. J., Giudice, L. C., Stein, E., Asher, A., Chang, S., Gorman, R., Ghany, M. G., T Liang, J., Wierzbicki, M. R., Scarselli, E., Nicosia, A., Folgori, A., Capone, S., and Cox, A. L., Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection., N Engl J Med, vol. 384, no. 6, pp. 541-549, 2021.
S. R. Morris, Bristow, C. C., Wierzbicki, M. R., Sarno, M., Asbel, L., French, A., Gaydos, C. A., Hazan, L., Mena, L., Madhivanan, P., Philip, S., Schwartz, S., Brown, C., Styers, D., Waymer, T., and Klausner, J. D., Performance of a single-use, rapid, point-of-care PCR device for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: a cross-sectional study., Lancet Infect Dis, vol. 21, no. 5, pp. 668-676, 2021.
C. W. Woods, Sanchez, A. M., Swamy, G. K., McClain, M. T., Harrington, L., Freeman, D., Poore, E. A., Slifka, D. K., DeRaad, D. E. Poer, Amanna, I. J., Slifka, M. K., Cai, S., Shahamatdar, V., Wierzbicki, M. R., Amegashie, C., and Walter, E. B., An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults., Vaccine, vol. 37, no. 30, pp. 4222-4230, 2019.
J. C. Dombrowski, Wierzbicki, M. R., Newman, L. M., Powell, J. A., Miller, A., Dithmer, D., Soge, O. O., and Mayer, K. H., Doxycycline Versus Azithromycin for the Treatment of Rectal Chlamydia in Men Who Have Sex With Men: A Randomized Controlled Trial, Clin Infect Dis, 2021.